Frazier to Retire After 30 years at Merck; Board Elects Davis as Company Chairman RAHWAY, N.J.–(BUSINESS WIRE)–$MRK #MRK–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Merck board of directors has unanimously elected Robert M. Davis to serve as chairman of the board, effective Dec. 1, 2022. He … [Read more…]
NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced its fourth annual “Crush the Crisis” national opioid take back day to raise awareness about the dangers of opioid misuse and the importance of safe and proper disposal of unused or expired medications, on Saturday, October 29, 2022. More than … [Read more…]
Management to host investor conference call and webcast at 5:00pm ET on that day NEW YORK–(BUSINESS WIRE)–DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the third quarter ended September 30, 2022, after the markets close on Monday, November 7. Management will host a … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “US Lymphocytic Leukemia Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Lymphocytic Leukemia pipeline products, Lymphocytic Leukemia epidemiology, Lymphocytic Leukemia market valuations and forecast, Lymphocytic Leukemia drugs sales and competitive landscape in the US. The research is classified into seven sections – … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “US Chronic Obstructive Pulmonary Disease Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Chronic Obstructive Pulmonary Disease pipeline products, Chronic Obstructive Pulmonary Disease epidemiology, Chronic Obstructive Pulmonary Disease market valuations and forecast, Chronic Obstructive Pulmonary Disease drugs sales and competitive landscape in … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “US Alcohol Dependence Market and Competitive Landscape – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insights into Alcohol Dependence pipeline products, Alcohol Dependence epidemiology, Alcohol Dependence market valuations and forecast, Alcohol Dependence drugs sales and competitive landscape in the US. The research is classified into seven sections – … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Smoking Cessation Clinical Trial Pipeline Highlights – 2022” report has been added to ResearchAndMarkets.com’s offering. The report provides the most up-to-date information on key pipeline products within the global Smoking Cessation market. It covers emerging therapies for Smoking Cessation in active clinical development stages including early and late stage clinical trials. The … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Sterile Filtration – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Sterile Filtration Market to Reach $7.8 Billion by 2027 Amid the COVID-19 crisis, the global market for Sterile Filtration estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Intravenous Solutions Market, by Solution, by Bag Type, by Application, by End User, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, non-pyrogenic … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biopharmaceuticals Contract Manufacturing – Market Insights, Competitive Landscape and Market Forecast-2027” report has been added to ResearchAndMarkets.com’s offering. The global biopharmaceuticals contract manufacturing market estimated to advance at a 7.38% CAGR during the forecast period from 2022 to 2027. Company Profiles Boehringer Ingelheim International GmbH Lonza Rentschler Biopharma SE BINEX Co., Ltd. INCOG … [Read more…]
